Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
Authors
Keywords
-
Journal
Cells
Volume 12, Issue 21, Pages 2575
Publisher
MDPI AG
Online
2023-11-05
DOI
10.3390/cells12212575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer
- (2022) Lyndsey A. Reich et al. Scientific Reports
- A novel mouse model of cutaneous T‐cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy
- (2022) Keiko Nakahashi et al. EXPERIMENTAL DERMATOLOGY
- Cutaneous T‐cell lymphomas—An update 2021
- (2021) Werner Kempf et al. HEMATOLOGICAL ONCOLOGY
- Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB)
- (2021) Peter W. Jurutka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers
- (2019) Wei Wang et al. Journal of Natural Medicines
- A review of the molecular design and biological activities of RXR agonists
- (2019) Nathalia Rodrigues Almeida et al. MEDICINAL RESEARCH REVIEWS
- The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis
- (2018) Chu-Fang Chou et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
- (2018) Bentley J. Hanish et al. STEROIDS
- Overview of the Use of Murine Models in Leukemia and Lymphoma Research
- (2017) Rebecca Kohnken et al. Frontiers in Oncology
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
- (2016) Travis T. Wager et al. ACS Chemical Neuroscience
- Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
- (2016) A. Mishra et al. Cancer Discovery
- Sézary Syndrome: Clinical and Biological Aspects
- (2016) Rebecca Kohnken et al. Current Hematologic Malignancy Reports
- DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
- (2015) Thomas Sander et al. Journal of Chemical Information and Modeling
- ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice
- (2015) Angela W. Corona et al. Journal of Neuroimmune Pharmacology
- ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
- (2015) Tauno Metsalu et al. NUCLEIC ACIDS RESEARCH
- PLCG1 mutations in cutaneous T-cell lymphomas
- (2014) José P. Vaqué et al. BLOOD
- RA induces differentiation of multipotent P19 cells towards male germ cell
- (2014) Lei Zhang et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- RXR Partial Agonist Produced by Side Chain Repositioning of Alkoxy RXR Full Agonist Retains Antitype 2 Diabetes Activity without the Adverse Effects
- (2014) Kohei Kawata et al. JOURNAL OF MEDICINAL CHEMISTRY
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
- (2014) Sarah I. Jawed et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
- (2014) Sarah I. Jawed et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic Acid (CD3254)
- (2013) Peter W. Jurutka et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel mouse model for Sézary Syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2−/−γc−/−mice
- (2012) Leslie van der Fits et al. EXPERIMENTAL DERMATOLOGY
- Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma
- (2010) Sara Samimi et al. ARCHIVES OF DERMATOLOGY
- A mouse model for the Sézary syndrome
- (2010) Udo Doebbeling JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma
- (2010) Christoph Schlapbach et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cancer-Associated Myeloproliferation: Old Association, New Therapeutic Target
- (2010) Ryan A. Wilcox MAYO CLINIC PROCEEDINGS
- Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
- (2009) P. T. Bradford et al. BLOOD
- Update on treatment of cutaneous T-cell lymphoma
- (2009) Jennifer M Gardner et al. CURRENT OPINION IN ONCOLOGY
- Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene)
- (2009) Carl E. Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation